Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "safety"

1849 News Found

Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures
News | April 09, 2026

Johnson & Johnson unveils Varipulse Pro in Europe for faster & safer heart procedures

The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect


Chiba University study flags allergy risk in high-binding antibody drugs
Biopharma | April 09, 2026

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms


Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle
Healthcare | April 09, 2026

Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle

36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108


Kokilaben hospital performs first remote robotic kidney surgery
Hospitals | April 09, 2026

Kokilaben hospital performs first remote robotic kidney surgery

Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat


Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
News | April 09, 2026

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms


Asia emerges new hotspot for healthcare ransomware, says report
Digitisation | April 08, 2026

Asia emerges new hotspot for healthcare ransomware, says report

Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs


Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026
Clinical Trials | April 08, 2026

Moderna to reveal late-breaking data on flu & RSV mRNA vax at ESCMID 2026

The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21


Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy
Clinical Trials | April 08, 2026

Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy

The trial also demonstrated significant improvements across multiple secondary endpoints


Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
Biotech | April 06, 2026

Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial

Safety was equally impressive. ENV-294 was well tolerated


SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
Healthcare | April 06, 2026

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education

Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings